News

Immunetune is proud to have been selected as one of the Top 25 of the 2020 Blue Tulip Awards in the category Health! Click here for more information.

CEO Gerben Zondag will present Immunetune's unique platform that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming Neoantigen Summit Europe, 7-9 April in Amsterdam.

Immunetune was featured in the December 2019 issue of Biotech News & Life Science, read the full article here (in Dutch only).

Immunetune is proud to have been selected as one of the Top 25 of the 2020 Blue Tulip Awards in the category Health! Click here for more information.

CEO Gerben Zondag will present Immunetune's unique platform that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming Neoantigen Summit Europe, 7-9 April in Amsterdam.

Immunetune was featured in the December 2019 issue of Biotech News & Life Science, read the full article here (in Dutch only).

Immunetune will be attending Biotech Wednesday on November 20 in Utrecht, the Netherlands. Reach out to us through the networking app or contact us directly in case you'd like to learn more about Immunetune's approach to fight cancer. More information on this meeting...